| Dividendenbekanntmachungen (20.04.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADECCO GROUP AG CH0012138605 1 CHF 1,0875 EUR ANIMA HOLDING SPA IT0004998065 - 0,5 EUR BANCA MEDIOLANUM SPA IT0004776628 - 0,65... ► Artikel lesen |
| Dividendenbekanntmachungen (16.01.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABBVIE INC US00287Y1091 1,73 USD 1,4902 EUR ABBVIE INC CDR CA00288K1084 0,2439 CAD 0,1512 EUR ALAMO GROUP INC US0113111076 0... ► Artikel lesen |
| XFRA NEW INSTRUMENTS AVAILABLE ON 03.02.2026 | The following instruments on XETRA do have their first trading 03.02.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 03.02.2026
Aktien
1 AU0000292112 Foresta Group Holding... ► Artikel lesen |
| Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy | SAN JOSE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. ("Rani Therapeutics" or "Rani") (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery... ► Artikel lesen |
| Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization | SAN JOSE, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. ("Rani Therapeutics" or "Rani") (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery... ► Artikel lesen |
| Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer | SAN JOSE, Calif., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. ("Rani Therapeutics" or "Rani") (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery... ► Artikel lesen |